Reactive Lymphadenopathy During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Two Case Reports
Background: Tyrosine kinase inhibitors (TKIs) are the cornerstone of chronic myeloid leukemia (CML) therapy. Although generally well tolerated, they may have adverse effects that warrant attention and are rarely documented such as lymphadenopathy mimicking disease progression and prompting unnecessa...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine
2026-06-01
|
| Series: | Research in Oncology |
| Assuntos: | |
| Acceso en liña: | https://resoncol.journals.ekb.eg/article_516219_191d250c402e65ff9610ce9fb7abf734.pdf |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|